We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

Fri, 24th Jan 2014 10:58

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday.

-------

FTSE 100 - WINNERS

Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide general maintenance services on Lukoil's West Qurna-2 oilfield in southern Iraq.

-------

FTSE 250 - WINNERS

Close Brothers Group, up 1.7%. The financial services company said it is expecting a strong result for the first-half of its financial year, as the recovering economy boosted all three of its divisions. Close Brothers said its positive first-quarter performance has so far carried on into the second quarter, adding that it is confident in its outlook for the full financial year.

-------

FTSE 250 - LOSERS

Cairn Energy, down 4.2%. The oil and gas exploration company said it has been contacted by the Income Tax Department of India to discuss previous income tax assessments. It said the discussions cover tax assessments from the year ending March 31, 2007. While the discussions are taking place, the Income Tax Department has instructed Cairn to hold its shares in Cairn India Ltd.

-------

AIM - WINNERS

Victoria Oil & Gas, up 15%. The oil and gas exploration and development company said it has signed a settlement agreement with RSM Production Corp in relation to its cash-call dispute for the Logbaba gas project in Cameroon. Victoria said that the parties have agreed to an independent audit to determine the final balance payable by, or to be refunded to, RSM. The audit is due to start during the first quarter and be completed within 90 days.

ITM Power, up 12%. The energy storage and clean fuel company said it has secured a contract with AMEC and National Grid to assess efficient usage of Power-to-Gas energy storage. The project will look at the cost and energy benefit of deploying Power-to-Gas technology at specific sites on the UK gas network. Power-to-Gas is a technology which converts electrical power to a gas fuel.

Stadium Group, up 11%. The electronic technologies company said that it had traded in line with expectations in 2013. The company said that, as it had expected, it delivered "significantly improved" profits in the second half as it began to see benefits from its restructuring programme.

President Energy, up 7%. The company said the results of an independent audit of its prospective resources are substantially better than expectations. The company said its three drilling target prospect areas in Paraguay are now estimated to have a gross mean unrisked prospective resource of 1.09 billion barrels of oil equivalent, which equates to 647 million barrels of mean unrisked oil equivalent to President and 130 million barrels of mean risked resources. President Energy said earlier this month that the sites were expected to have a gross risked resource potential of in excess of 500 million barrels of oil equivalent.

Stellar Resources, up 6.7%. The company said Gold Mines of Wales (Operations) Ltd, in which Stellar owns 49.9%, agreed a 12-month extension of its exclusive option agreement with the Crown Estates.

-------

AIM - LOSERS

Strategic Minerals, off 28%. The company, which experienced a 94% increase in its share price in the week between January 15 and January 22, said it knows of no reason for its sharp drop in share price.

Akers Biosciences, down 15%. The company's shares have plummeted after it recommenced trading on the alternative market. The company also announced late on Thursday the pricing of its public offering on the NASDAQ. Akers will offer 2.7 million shares at USD5.50 each, hoping to raise around USD15 million in gross proceeds.

E-Therapeutics, down 18%. The firm has announced the temporary halt of recruitment into ETS2101 cancer trials because of a drug supply issue. Patients already receiving treatment will continue to be dosed in accordance with trial protocols.

Biome Technologies, down 11%. Biome said that it expects to meet forecasts for its full-year results. However, it noted that its Stanelco RF Technologies business had seen a subdued end to the year due to turbulence in the Chinese fibre optic market.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.